Congratulations to Anil Chekuri, PhD (Harvard Medical School; Massachusetts Eye and Ear, Boston) for receiving the 2026 Bert M. Glaser, MD, Award for Innovative Research given by the ARVO Foundation for Eye Research. The image features a professional headshot of Anil Chekuri against a blue and white geometric background.

@arvoinfo.bsky.social Foundation congratulates Anil Kumar Chekuri, PhD (Mass Eye and Ear)—2026 recipient of the Bert M. Glaser, MD Award for Innovative Research in #Retina. Learn more about his outstanding contributions to gene therapy for #RetinalDegeneration: https://bit.ly/3NqPOSL
#VisionResearch

Molecular underpinnings of induced degenerative heterogeneity in the retinal pigment epithelium | PNAS Cigarette smoking induces epigenetic changes that can cause degenerative heterogeneity with aging and disease. In disease such as age-related macul...

Epigenetics Update - Molecular underpinnings of induced degenerative heterogeneity in the retinal pigment epithelium bit.ly/3Zop084

James T. Handa (Johns Hopkins) reported in PNAS

#Epigenetics #RPE #RetinalDegeneration
---

Discover the breakthrough at epigenometech.com

Safety and neuroprotective efficacy of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo study - BMC Medicine Background Retinal degenerative diseases represent a complex global health problem due to their significant impact on patients’ daily lives and their highly heterogeneous pathogenesis, which challenge...

Excited to share that our research is now published!
Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors!
🔗 link.springer.com/article/10.1...
@eye-tuebingen.bsky.social
#Proteostasis #VCP #RetinalDegeneration #PreclinicalResearch

Two weeks of wonderful conferences coming to an end 👋 I presented our lab work on the #RDmeeting2025 in Prague and on the #ERM2025 in Pecs. #retina #retinalneuroscience #retinaldegeneration #RPE #AMD

🧬 New study: #CERKL-associated #retinaldegeneration in Portugal 🇵🇹
🧑‍⚕️21 families w/cone-rod dystrophy, #RP-like
📌Early macular atrophy
🔍 4 novel mutations
⚠️Severe, early disease—even w/o consanguinity

🔗Link here: www.sciencedirect.com/science/arti...
#AJOInternational #InheritedRetinalDisorder #CERKL

Deletion of Emc6 in rod cells using a rod- and cone-specific Emc6 knockout model led to early-onset #RetinalDegeneration & mislocalization of rhodopsin and other membrane disc proteins, highlighting EMC6’s essential role in the synthesis and transport of #Rhodopsin in retinal

buff.ly/xHQ8Pgu

Reclaiming Sight When It’s Almost Gone Penn researchers have developed breakthrough genetic “switches” that could make gene therapy possible even in advanced vision loss—offering a second chance to see for patients previously out of reach.

New gene therapy tools target vision loss at advanced stages—offering hope where none existed before. #visionrestoration #genetherapy #retinaldegeneration

Improvements induced by retinal gene therapy with voretigene neparvovec depend on visual cortical hemispheric dominance mechanisms - Communications Medicine Ferreira, M et al. investigate the cortical response to visual function restoration in 10 patients with RPE65-RD treated with voretigene neparvovec using psychophysical and neuroimaging methods. The authors found significant improvements in light sensitivity and neural response under low luminance conditions, particularly in the right hemisphere.

🚨 NEW RESEARCH! 👀

Ferreira et al. show the combined restorative effects of #genetherapy and testing of cortical response to visual function in 10 patients with RPE65-associated retinal degeneration.

https://bit.ly/3Gvy3y1
#RetinalDegeneration

Image featuring a congratulatory message to Ximena Corso-Diaz, recipient of the 2025 Genentech Career Development Award for URM Emerging Vision Scientists, presented by the ARVO Foundation for Eye Research. Includes a professional portrait of Ximena Corso-Diaz with ARVO Foundation logo at the bottom.

@arvoinfo.bsky.social congratulates Ximena Corso-Díaz, MSc, PhD (@stanford.edu)—recipient of the 2025 @genentech.bsky.social Career Development Award for #UnderrepresentedMinority Emerging Vision Scientists. Learn about her research on preventing #RetinalDegeneration: bit.ly/42mE8FU